Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PABPC1L2B antisense RNA 1 (PABPC1L2B-AS1) is a long non-coding RNA (lncRNA) gene found on the X chromosome, transcribed in a head-to-head (bidirectional) antisense orientation. It consists of four exons and has a transcript size of 1167 bases. Computational assessments and database annotation confirm its non-coding nature, and there is no evidence of protein-coding potential. There is currently no literature describing its biological function, disease relevance, or association with drug interactions. This transcript is cataloged in several genomic databases under multiple identifiers, but its molecular and clinical significance is unknown. PABPC1L2B-AS1 shares nomenclature similarity to protein-coding genes involved in mRNA stabilization/translation, such as PABPC1, but is distinct in sequence, regulatory architecture, and lacks evidence of translation or direct involvement in these processes. The lack of available literature and functional reports in major databases indicates this is a non-protein-coding locus with no current therapeutic, biomarker, or disease relevance. Summary: PABPC1L2B antisense RNA 1 (PABPC1L2B-AS1) is a catalogued long non-coding antisense RNA gene without described biological function, disease roles, or drug interactions. It should not be considered a pharmacological target or biomarker at present, and information about it is extremely limited or absent in the scientific literature.
None (No known mechanism of drug action because it is not an established drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PABPC1L2B antisense RNA 1 (head to head) (PABPC1L2B-AS1).